Literature DB >> 32253420

Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.

Michael J Hwang1, Ashish M Kamat2, Colin P Dinney2, Bogdan Czerniak1, Charles C Guo1.   

Abstract

OBJECTIVES: Bladder cancers invading the muscularis mucosae (MM) are treated differently from those invading the muscularis propria (MP). However, it may be difficult to determine the type of smooth muscle in transurethral resection (TUR) or biopsy specimens. We aimed to investigate the clinicopathologic features of bladder cancers involving smooth muscle of indeterminate type (SMIT) in TUR specimens in comparison with those invading the MM.
METHODS: We identified 103 patients with bladder cancer involving SMIT (n = 27) or the MM (n = 76) in TUR specimens. All patients underwent subsequent restaging TUR or cystectomy.
RESULTS: Bladder cancer with SMIT invasion showed a significantly higher rate of MP invasion in the subsequent specimens than those invading the MM (52% vs 29%). Lack of MP in the TUR specimens had a significantly higher risk of MP invasion in the subsequent specimens than those with the MP (61% vs 40%). The overall survival time for patients with SMIT invasion was significantly shorter than those with MM invasion.
CONCLUSIONS: Bladder cancers with SMIT invasion in TUR specimens show more frequent cancer upstaging in the subsequent specimens and a poorer clinical outcome than those invading the MM, which highlights the importance of a cancer restaging procedure for these patients. © American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Bladder cancer; Muscularis mucosae; Muscularis propria; Smooth muscle invasion; Smooth muscle of indeterminate type

Mesh:

Year:  2020        PMID: 32253420      PMCID: PMC7768762          DOI: 10.1093/ajcp/aqaa030

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  28 in total

1.  Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base.

Authors:  Phillip J Gray; Chun Chieh Lin; Ahmedin Jemal; William U Shipley; Stacey A Fedewa; Adam S Kibel; Jonathan E Rosenberg; Ashish M Kamat; Katherine S Virgo; Michael L Blute; Anthony L Zietman; Jason A Efstathiou
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-01       Impact factor: 7.038

2.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

3.  Transurethral resection specimens of the bladder: outcome of invasive urothelial cancer involving muscle bundles indeterminate between muscularis mucosae and muscularis propria.

Authors:  Hiroshi Miyamoto; Jonathan I Epstein
Journal:  Urology       Date:  2010-04-14       Impact factor: 2.649

4.  Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens.

Authors:  Gladell P Paner; Jeffrey G Brown; Shawn Lapetino; Nalan Nese; Ruta Gupta; Steven S Shen; Donna E Hansel; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2010-06       Impact factor: 6.394

Review 5.  Variant histology: role in management and prognosis of nonmuscle invasive bladder cancer.

Authors:  Sima P Porten; Daniel Willis; Ashish M Kamat
Journal:  Curr Opin Urol       Date:  2014-09       Impact factor: 2.309

6.  Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

Authors:  Sam S Chang; Bernard H Bochner; Roger Chou; Robert Dreicer; Ashish M Kamat; Seth P Lerner; Yair Lotan; Joshua J Meeks; Jeff M Michalski; Todd M Morgan; Diane Z Quale; Jonathan E Rosenberg; Anthony L Zietman; Jeffrey M Holzbeierlein
Journal:  J Urol       Date:  2017-04-26       Impact factor: 7.450

7.  Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.

Authors:  Gladell P Paner; Steven S Shen; Shawn Lapetino; Girish Venkataraman; Güliz A Barkan; Marcus L Quek; Jae Y Ro; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

8.  The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma.

Authors:  Ashish M Kamat; Jason R Gee; Colin P N Dinney; H Barton Grossman; David A Swanson; Randall E Millikan; Michelle A Detry; Tracy L Robinson; Louis L Pisters
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

9.  Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

Authors:  J Alfred Witjes; Thierry Lebret; Eva M Compérat; Nigel C Cowan; Maria De Santis; Harman Maxim Bruins; Virginia Hernández; Estefania Linares Espinós; James Dunn; Mathieu Rouanne; Yann Neuzillet; Erik Veskimäe; Antoine G van der Heijden; Georgios Gakis; Maria J Ribal
Journal:  Eur Urol       Date:  2016-06-30       Impact factor: 20.096

Review 10.  Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.

Authors:  Sam S Chang; Stephen A Boorjian; Roger Chou; Peter E Clark; Siamak Daneshmand; Badrinath R Konety; Raj Pruthi; Diane Z Quale; Chad R Ritch; John D Seigne; Eila Curlee Skinner; Norm D Smith; James M McKiernan
Journal:  J Urol       Date:  2016-06-16       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.